- During an acute stress test, subjects receive an infusion of cortisol that raises plasma cortisol to 800 nM for 6 hours. Compared with placebo, fasting plasma glucose the next morning is modestly higher (by ~0.6 mM), while plasma insulin is also higher. Which change is most consistent with cortisol's role in metabolic regulation over this time scale?
Answer: Increased hepatic gluconeogenic capacity, contributing to higher glucose and compensatory hyperinsulinemia
This question tests understanding of cortisol's metabolic effects over hours to days. Cortisol is a glucocorticoid hormone that acts through nuclear receptors to induce transcription of gluconeogenic enzymes (PEPCK, G6Pase) in the liver, increasing the capacity for glucose production from amino acids. This genomic effect requires several hours to manifest, explaining the delayed increase in fasting glucose the next morning. The correct answer (B) accurately describes increased hepatic gluconeogenic capacity leading to higher glucose production, which triggers compensatory insulin secretion to maintain glucose homeostasis. Answer A incorrectly suggests cortisol decreases gluconeogenesis, when it actually enhances it through transcriptional upregulation. When analyzing steroid hormone effects, remember they act through gene transcription requiring hours, unlike peptide hormones that signal within minutes through second messengers.
- A 35-year-old with an insulin-secreting pancreatic tumor has recurrent fasting hypoglycemia. During an episode, labs show: glucose 2.2 mM, insulin high, C-peptide high, and low plasma free fatty acids. The clinician explains that one reason symptoms occur rapidly is reduced availability of alternative fuels for the brain. Which process is most likely suppressed by the patient's hormonal state?
Answer: Adipose lipolysis, limiting fatty acid and glycerol release
This question tests metabolic regulation and hormonal integration, highlighting insulin's role in suppressing alternative fuel release during hypoglycemia. Hormonal control prioritizes glucose storage under high insulin, inhibiting catabolic processes like lipolysis to favor carbohydrate use. In this vignette, the insulinoma's high insulin suppresses lipolysis, leading to low free fatty acids and rapid symptoms from limited brain fuels. Adipose lipolysis, limiting fatty acid and glycerol release (choice B) is suppressed, reducing alternative fuels as high insulin inhibits hormone-sensitive lipase. A common distractor, such as increased hepatic gluconeogenesis (choice A), fails as high insulin suppresses, not promotes, this process. To apply this, identify if hyperinsulinemia restricts catabolic substrate release in hypoglycemic states. Verify by correlating low metabolites like FFAs with insulin-driven suppression.
- A hospitalized patient is started on a high-dose exogenous thyroid hormone regimen. After 2 weeks, resting oxygen consumption increases, and the patient reports increased appetite with mild weight loss. Fasting insulin is slightly increased, while fasting glucose remains within the normal range. Which change is most consistent with thyroid hormone's integration with metabolic regulation in this scenario?
Answer: Increased basal metabolic rate with increased ATP turnover and heat production
This question tests understanding of thyroid hormone's effects on basal metabolism and energy expenditure. Thyroid hormones increase basal metabolic rate by multiple mechanisms including increased mitochondrial biogenesis, enhanced Na+/K+-ATPase activity, and increased substrate cycling. The clinical findings of increased oxygen consumption, increased appetite, and mild weight loss despite increased food intake all indicate elevated metabolic rate. The correct answer (B) accurately describes thyroid hormone's effect of increasing ATP turnover and heat production, explaining the observed hypermetabolic state. Choice A is incorrect as it describes the opposite effect - thyroid hormone increases, not decreases, mitochondrial oxidative capacity. To analyze thyroid hormone effects, look for changes in basal energy expenditure and remember that hyperthyroidism creates a hypermetabolic state requiring increased fuel oxidation.
- During a graded cycling test, participants exercised at 70% of V˙O2 max for 30 minutes. Blood samples showed a rapid rise in plasma epinephrine within 5 minutes, while insulin fell slightly. In a subset given a nonselective β-adrenergic antagonist before exercise, the rise in plasma lactate was blunted despite similar workload. Based on the vignette, which process is most likely reduced by β-adrenergic blockade during exercise?
Answer: Skeletal muscle glycogen breakdown that supplies substrate for glycolysis
This question tests understanding of catecholamine signaling during exercise and its metabolic effects. Epinephrine activates β-adrenergic receptors on skeletal muscle, triggering cAMP-PKA signaling that promotes rapid energy mobilization. The rise in plasma lactate during exercise reflects increased glycolytic flux, partly from muscle glycogen breakdown providing glucose-6-phosphate for glycolysis. The correct answer (C) is supported by the blunted lactate response with β-blockade, indicating reduced glycogen breakdown and subsequent glycolysis when adrenergic signaling is blocked. Choice B is incorrect because insulin levels fall during exercise and adipose tissue plays a minor role in acute lactate production. To verify metabolic responses to exercise, consider which tissues are actively contracting, what fuels they require immediately, and how hormonal changes support rapid ATP generation rather than storage processes.
- In a study of postprandial regulation, participants ingest 75 g glucose. One group receives a drug that blocks intestinal incretin signaling. Compared with placebo, this group shows a smaller early insulin rise (0–30 min) but similar glucose by 180 min. Which compensatory change most likely helps normalize glucose later in the incretin-blocked group?
Answer: Delayed but increased insulin secretion driven by rising plasma glucose
This question tests metabolic regulation and hormonal integration, addressing incretins' potentiation of insulin secretion post-glucose ingestion. Hormones and incretins amplify beta-cell responses, ensuring timely insulin release for glucose disposal. In this vignette, blunted early insulin with incretin blockade but later normalization connects to compensatory mechanisms. Delayed but increased insulin secretion driven by rising plasma glucose (choice D) helps normalize, as hyperglycemia directly stimulates beta cells. A common distractor, such as increased glucagon secretion (choice B), fails as incretins suppress glucagon. To apply this, evaluate if incretin loss shifts reliance to direct glucose stimulation. Confirm by tracking insulin curves against glucose excursions.
- A 28-year-old participant completes a 36-hour fast with free water access. At hour 36, labs show plasma glucose 3.6mM, insulin low, glucagon high, and plasma ketone bodies 4.2mM. The participant then receives an IV bolus of glucagon. Which process is most likely regulated directly by glucagon in hepatocytes under these conditions?
Answer: Activation of glycogen phosphorylase via cAMP/PKA signaling
This question tests understanding of glucagon's direct hepatic actions during prolonged fasting when ketone bodies are elevated. Glucagon acts through cAMP/PKA signaling to mobilize energy stores and maintain glucose homeostasis during fasting states. In hepatocytes, glucagon directly activates adenylyl cyclase, increasing cAMP and activating PKA, which phosphorylates and activates glycogen phosphorylase while inhibiting glycogen synthase. The correct answer (D) accurately describes this direct signaling cascade that promotes glycogen breakdown. Choice B incorrectly describes GLUT4 translocation, which is insulin-mediated and occurs in muscle/adipose tissue, not hepatocytes responding to glucagon. When evaluating hormonal effects, distinguish between direct receptor-mediated actions (glucagon→cAMP→PKA→phosphorylase) and indirect metabolic consequences - this helps identify the primary regulated process in any tissue.
- In a study of acute stress, subjects receive an epinephrine infusion for 20 minutes. Plasma lactate rises from 1.0 to 3.5 mM while plasma glucose rises modestly from 4.8 to 5.4 mM. The investigator attributes the lactate increase to skeletal muscle metabolism under adrenergic signaling. Which outcome is most consistent with epinephrine action in skeletal muscle?
Answer: Increased glycogen breakdown with enhanced glycolytic flux producing lactate
This question tests metabolic regulation and hormonal integration, examining epinephrine's stimulation of muscle glycolysis under stress. Hormones like epinephrine activate catabolic pathways in muscle to generate energy and intermediates like lactate for hepatic use. In this vignette, rising lactate during epinephrine infusion connects to enhanced muscle glycogen breakdown and glycolytic flux. Increased glycogen breakdown with enhanced glycolytic flux producing lactate (choice D) follows from epinephrine's activation of phosphorylase and glycolysis. A common distractor, such as increased glycogen synthesis (choice C), fails as epinephrine promotes breakdown, not synthesis. To apply this, evaluate if catecholamines drive anaerobic metabolite production in peripheral tissues. Confirm by tracking lactate levels against adrenergic signaling markers.
- In a crossover study, 12 healthy adults completed two 90-minute sessions after an overnight fast. In one session they received a continuous infusion of insulin (target plasma insulin 60
0
0pM) with euglycemic clamp (plasma glucose maintained at 5.0±0.2mM). In the other session they received saline. A microdialysis probe sampled interstitial fluid from vastus lateralis, and muscle biopsies were assayed for glycogen content. At 90 minutes, insulin increased whole-body glucose infusion rate required to maintain euglycemia, while plasma free fatty acids fell from 0.55 to 0.18mM. Which outcome is most consistent with insulin s integrated action on skeletal muscle metabolism during the clamp?
Answer: Increased glycogen synthase activity leading to increased muscle glycogen content
This question tests understanding of insulin's integrated metabolic effects during a euglycemic clamp, specifically its action on skeletal muscle glucose metabolism. Insulin promotes anabolic processes by activating glucose uptake through GLUT4 translocation and stimulating glycogen synthesis while inhibiting lipolysis. During the euglycemic clamp, insulin levels are elevated while glucose is maintained constant through exogenous infusion, creating conditions that favor glucose storage. The correct answer (B) follows logically because insulin activates glycogen synthase through dephosphorylation via protein phosphatase 1, leading to increased muscle glycogen content when glucose is readily available. Choice A incorrectly suggests decreased GLUT4 translocation, which contradicts insulin's primary action of increasing glucose uptake. To verify insulin's anabolic effects, check whether the hormone promotes storage pathways (glycogen synthesis, lipogenesis) while suppressing catabolic pathways (lipolysis, glycogenolysis) - this principle applies across metabolic tissues.
- In a crossover study, 10 healthy volunteers completed two 24-hour conditions: (i) overnight fast with water only and (ii) overnight fast plus a continuous low-dose glucagon infusion from 06:00–10:00. At 10:00, plasma glucose was similar in both conditions (fast: 4.6 mM; glucagon: 4.7 mM), but plasma free fatty acids were higher with glucagon (0.82 vs 0.54 mM). Investigators propose the glucose similarity reflects compensatory substrate use rather than identical hepatic fluxes. Based on the vignette, which outcome is most consistent with glucagon action during the infusion?
Answer: Increased adipose lipolysis with greater delivery of glycerol to the liver
This question tests the understanding of metabolic regulation and hormonal integration, specifically glucagon's role in coordinating lipid and carbohydrate metabolism during fasting. Hormones like glucagon promote catabolic processes to maintain energy homeostasis, stimulating hepatic glucose production and adipose lipolysis to provide substrates. In this vignette, the glucagon infusion maintains similar plasma glucose levels despite elevated free fatty acids, highlighting integrated compensatory mechanisms in hepatic fluxes. Increased adipose lipolysis with greater delivery of glycerol to the liver (choice C) follows logically as glucagon activates lipolysis, supplying glycerol for hepatic gluconeogenesis to sustain glucose without net change. A common distractor, such as increased skeletal muscle glucose uptake via GLUT4 (choice D), fails because glucagon opposes insulin-mediated uptake, not promoting it during fasting. To apply this reasoning, evaluate if the hormone enhances alternative substrate mobilization like lipolysis in low-glucose states. Additionally, confirm if metabolite profiles, such as elevated FFAs, align with the hormone's catabolic effects on adipose tissue.
- In an experiment on hormonal integration during feeding, subjects ingest a mixed meal (75 g carbohydrate, 25 g protein, 20 g fat). At 45 minutes, plasma glucose is 7.4mM and insulin is elevated. A subset receives an infusion of somatostatin to suppress pancreatic hormone secretion; basal replacement insulin is provided to maintain fasting insulin levels, but glucagon is not replaced. Compared with untreated controls, which outcome is most likely in the somatostatin group over the next hour?
Answer: Reduced hepatic glycogen synthesis due to lower portal insulin and relatively higher glucagon action
This question tests understanding of integrated pancreatic hormone effects on postprandial metabolism. During normal meal absorption, insulin rises to promote glucose uptake and storage while glucagon is suppressed, creating a high insulin:glucagon ratio that favors anabolism. Somatostatin suppresses both insulin and glucagon secretion; with only basal insulin replacement and no glucagon replacement, the insulin:glucagon ratio becomes abnormally low in the portal circulation. The correct answer (A) follows because reduced portal insulin and relatively unopposed glucagon action impairs the normal postprandial shift toward hepatic glycogen synthesis. Choice D incorrectly invokes incretin effects, but somatostatin's primary action here is on pancreatic hormones, not intestinal incretin secretion. When analyzing hormonal integration, consider both absolute hormone levels and their ratios - the insulin:glucagon ratio is particularly critical for determining whether the liver engages in glucose storage or production.
- A subject is given a bolus of insulin and then performs light activity. Plasma glucose falls, but muscle glucose uptake increases. The investigator notes that insulin's effect on muscle is amplified when muscle contraction is present, even without further increases in insulin. Which explanation best accounts for the increased muscle glucose uptake during contraction?
Answer: Contraction increases glucose transport through an insulin-independent pathway that also increases GLUT4 at the membrane
This question tests metabolic regulation and hormonal integration, highlighting exercise's additive effect on insulin-stimulated muscle glucose uptake. Hormonal and mechanical signals converge on GLUT4 translocation, with contraction providing an independent pathway. In this vignette, amplified uptake during activity connects to combined insulin and contraction stimuli. Contraction increases glucose transport through an insulin-independent pathway that also increases GLUT4 at the membrane (choice A) accounts for the increase. A common distractor, such as increased hepatic gluconeogenesis (choice B), fails as it doesn't directly affect muscle uptake. To apply this, evaluate if non-hormonal factors enhance insulin actions in muscle. Confirm by comparing uptake rates with and without contraction.
- During a euglycemic insulin clamp, investigators infuse insulin while maintaining plasma glucose at 5.0 mM with variable glucose infusion. They observe that hepatic glucose output decreases markedly, even though hepatocytes do not rely on GLUT4 for glucose entry. Which mechanism best explains insulin's suppression of hepatic glucose output in this setting?
Answer: Insulin decreases expression/activity of key gluconeogenic enzymes and promotes glycogen synthesis
This question tests metabolic regulation and hormonal integration, highlighting insulin's indirect suppression of hepatic glucose output. Hormones regulate liver metabolism via enzyme modulation, with insulin inhibiting gluconeogenesis without direct uptake effects. In this vignette, decreased output during clamp connects to insulin's signaling despite GLUT4 absence. Insulin decreases expression/activity of key gluconeogenic enzymes and promotes glycogen synthesis (choice D) explains suppression by shifting to storage. A common distractor, such as blocking export via GLUT4 (choice B), fails as liver uses GLUT2. To apply this, identify insulin mechanisms in non-GLUT4 tissues. Confirm by measuring output changes against infusion rates.
- A 45-year-old with type 1 diabetes accidentally administers excess rapid-acting insulin before a workout. Thirty minutes later, they develop neuroglycopenic symptoms; fingerstick glucose is 2.4mM. They self-administer intramuscular glucagon. Which change would be expected in metabolic rate and substrate flux most immediately after glucagon administration?
Answer: Increased hepatic glycogenolysis with increased glucose output to plasma
This question tests understanding of glucagon's immediate metabolic effects during insulin-induced hypoglycemia. Glucagon rapidly counteracts hypoglycemia by activating hepatic glycogenolysis through cAMP/PKA signaling, which phosphorylates and activates glycogen phosphorylase within minutes. In the context of excess insulin and severe hypoglycemia (2.4 mM), the most immediate need is to raise plasma glucose by mobilizing hepatic glycogen stores. The correct answer (A) correctly identifies increased hepatic glycogenolysis as glucagon's primary immediate action to restore euglycemia. Choice B incorrectly suggests insulin-independent GLUT4 translocation in muscle, which is not a glucagon effect and would worsen hypoglycemia by increasing glucose uptake. To predict acute hormonal responses, consider the hierarchy of counterregulatory mechanisms: hepatic glucose output occurs within minutes while other adaptations (ketogenesis, gluconeogenesis) require hours.
- A study examines the effect of somatostatin infusion on counterregulation during mild hypoglycemia (plasma glucose clamped at 3.2 mM). Somatostatin lowers both insulin and glucagon secretion. Compared with control, subjects require a higher exogenous glucose infusion rate to maintain the clamp. Which best explains this observation?
Answer: Reduced endogenous hepatic glucose production due to suppressed glucagon despite low insulin
This question tests metabolic regulation and hormonal integration, highlighting somatostatin's suppression of pancreatic hormones during hypoglycemia. Hormonal balance in counterregulation relies on glucagon to boost hepatic output when insulin is low. In this vignette, higher infusion need with somatostatin connects to impaired endogenous production. Reduced endogenous hepatic glucose production due to suppressed glucagon despite low insulin (choice A) explains the observation, as glucagon is key for HGP. A common distractor, such as increased HGP (choice B), fails with suppressed glucagon. To apply this, evaluate if hormone suppression disrupts counterregulatory glucose maintenance. Confirm by comparing infusion rates to hormonal profiles.
- A mouse model is engineered to express a constitutively active hepatic glucagon receptor. After a 16-hour fast, these mice have higher plasma glucose than wild-type despite similar insulin concentrations. Liver samples show increased phosphorylation of a key bifunctional enzyme that controls the balance between fructose-2,6-bisphosphate production and degradation. Based on the vignette, which metabolic change in the liver is most likely increased by this hormonal signaling state?
Answer: Gluconeogenic flux via decreased fructose-2,6-bisphosphate concentration
This question tests understanding of glucagon receptor signaling and its effects on hepatic glucose metabolism. Glucagon promotes catabolic processes by activating cAMP-dependent protein kinase A (PKA), which phosphorylates key regulatory enzymes to favor glucose production. The bifunctional enzyme mentioned is phosphofructokinase-2/fructose-2,6-bisphosphatase (PFK-2/FBPase-2), which when phosphorylated by PKA shifts to its phosphatase-active form, degrading fructose-2,6-bisphosphate (F-2,6-BP). The correct answer (B) follows because reduced F-2,6-BP levels relieve inhibition of fructose-1,6-bisphosphatase and reduce activation of phosphofructokinase-1, thereby favoring gluconeogenesis over glycolysis. Choice A is incorrect because increased F-2,6-BP would promote glycolysis, opposite to glucagon's catabolic effects. To verify answers in hormonal regulation questions, trace the signaling cascade from receptor activation through second messengers to the final metabolic outcome, ensuring each step aligns with the hormone's physiological role.
- A patient with untreated hyperthyroidism has resting oxygen consumption of 320 mL/min (normal ~250 mL/min) and reports weight loss despite increased appetite. Fasting plasma glucose is normal, but fasting plasma free fatty acids are mildly elevated. Which outcome is most consistent with thyroid hormone's integrated effect on metabolic rate and fuel handling?
Answer: Increased basal metabolic rate with enhanced sympathetic responsiveness, promoting lipolysis and elevated free fatty acids
This question tests understanding of thyroid hormone's effects on metabolic rate and fuel metabolism. Thyroid hormones increase basal metabolic rate by enhancing mitochondrial biogenesis, uncoupling proteins, and Na+/K+-ATPase activity, while also potentiating catecholamine signaling through increased β-adrenergic receptor expression. This creates a hypermetabolic state with increased oxygen consumption and enhanced lipolysis, providing free fatty acids as fuel for the elevated metabolic demands. The correct answer (B) accurately describes increased BMR with enhanced sympathetic responsiveness promoting lipolysis, explaining both the elevated oxygen consumption and free fatty acids. Answer A incorrectly suggests decreased BMR, which contradicts the observed increase in oxygen consumption and is opposite to thyroid hormone's known thermogenic effects. To analyze thyroid effects on metabolism, remember that hyperthyroidism creates a catabolic state with increased energy expenditure and enhanced sensitivity to counter-regulatory hormones.
- In a perfused rat liver preparation, investigators switch the perfusate from a fed-like hormone mix (insulin 100 pM, glucagon 20 pM) to a fasting-like mix (insulin 20 pM, glucagon 200 pM) while keeping substrate concentrations constant (lactate 2 mM, alanine 0.5 mM, glucose 5 mM). Within 10 minutes, net hepatic glucose release increases. Which regulatory event most likely accounts for the rapid increase in glucose output?
Answer: Activation of glycogen phosphorylase via phosphorylation downstream of cAMP/PKA, increasing glycogen breakdown
This question tests understanding of rapid hormonal regulation of hepatic glucose metabolism. The switch from fed-like to fasting-like hormone concentrations dramatically alters the insulin:glucagon ratio, shifting liver metabolism from storage to production mode. High glucagon activates adenylyl cyclase, increasing cAMP and PKA activity, which rapidly phosphorylates glycogen phosphorylase (activating it) and glycogen synthase (inhibiting it), leading to net glycogen breakdown. The correct answer (B) accurately describes this cAMP/PKA-mediated activation of glycogen phosphorylase as the primary mechanism for rapid glucose release. Answer A incorrectly suggests glycogen synthase activation, which would decrease rather than increase glucose output and is inhibited, not activated, by PKA phosphorylation. When analyzing acute metabolic shifts, focus on post-translational modifications (phosphorylation) for rapid responses within minutes, while transcriptional changes require hours.
- A researcher administers a single dose of a long-acting somatostatin analog to healthy volunteers. Two hours later, after a mixed meal, plasma glucose rises to 9.0 mM (controls: 7.2 mM) despite similar meal composition. Which hormonal integration best explains the higher postprandial glucose in the treated group?
Answer: Suppression of insulin secretion, reducing peripheral glucose uptake and limiting hepatic glycogen synthesis
This question tests understanding of somatostatin's role in coordinating postprandial glucose homeostasis. Somatostatin is a paracrine inhibitor that suppresses secretion of multiple hormones including insulin, glucagon, and GLP-1 from pancreatic and intestinal cells. By inhibiting insulin secretion with a somatostatin analog, the normal postprandial insulin response is blunted, reducing glucose uptake by peripheral tissues (muscle, adipose) and decreasing hepatic glucose storage as glycogen. The correct answer (D) logically explains the higher postprandial glucose through reduced insulin secretion and consequent impairment of glucose disposal. Answer B incorrectly suggests increased glucagon would increase hepatic glucose uptake, when glucagon actually promotes glucose release from liver. To understand integrated hormonal responses to meals, consider that insulin is the primary hormone for glucose disposal - blocking its secretion will impair the body's ability to clear absorbed glucose.
- A research team compares two groups during a 12-hour fast: Group X receives an infusion that blocks pancreatic glucagon secretion; Group Y receives saline. At 12 hours, Group X has lower plasma glucose (3.6 vs 4.3 mM) and lower plasma urea nitrogen. Which interpretation best explains both findings in Group X?
Answer: Reduced hepatic gluconeogenesis due to diminished glucagon signaling and reduced amino acid catabolism
This question tests metabolic regulation and hormonal integration, examining glucagon's role in gluconeogenesis and amino acid catabolism. Hormones like glucagon drive hepatic substrate use, increasing urea from protein breakdown during fasting. In this vignette, lower glucose and urea with glucagon blockade connect to reduced hepatic catabolism. Reduced hepatic gluconeogenesis due to diminished glucagon signaling and reduced amino acid catabolism (choice A) explains findings, as glucagon promotes both. A common distractor, such as increased glycogen synthesis due to epinephrine (choice B), fails without epinephrine mention. To apply this, evaluate if hormone blockade lowers catabolic products like urea. Confirm by comparing glucose and nitrogen markers across groups.
- A patient receives high-dose prednisone for an autoimmune flare. After 2 weeks, fasting plasma glucose increases from 5.1 to 6.4 mM, and fasting insulin is also elevated. The clinician suspects the hormone treatment altered hepatic glucose handling. Which outcome is most consistent with glucocorticoid effects integrated with insulin signaling?
Answer: Increased hepatic glucose production contributing to insulin resistance
This question tests metabolic regulation and hormonal integration, addressing glucocorticoids' induction of hepatic glucose production and insulin resistance. Hormones like cortisol promote catabolic states, enhancing gluconeogenesis and opposing insulin's effects. In this vignette, elevated glucose and insulin with prednisone link to disrupted hepatic insulin signaling. Increased hepatic glucose production contributing to insulin resistance (choice B) is consistent, as glucocorticoids upregulate gluconeogenic enzymes. A common distractor, such as decreased adipose lipolysis (choice D), fails as glucocorticoids promote it. To apply this, evaluate if steroids induce hyperglycemia via hepatic output. Confirm by tracking fasting glucose and insulin changes post-treatment.